Activist 13D/13G Filings - Trillium Therapeutics Inc. (TRIL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2021-11-19
06:44 am
Sale
13DTrillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC0
0%
-6,586,363decrease
(Position Closed)
View
2021-11-15
4:35 pm
Sale
13GTrillium Therapeutics Inc.
TRIL
RA CAPITAL MANAGEMENT L.P.0
0%
-5,290,481decrease
(Position Closed)
View
2021-08-31
6:43 pm
Unchanged
13DTrillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC6,586,363
6.3%
0
(Unchanged)
View
2021-04-07
4:32 pm
Unchanged
13GTrillium Therapeutics Inc.
TRIL
RA CAPITAL MANAGEMENT L.P.5,290,481
5.1%
0
(Unchanged)
View
2021-02-16
5:17 pm
Sale
13GTrillium Therapeutics Inc.
TRIL
Boxer Capital LLC0
0%
-4,425,000decrease
(Position Closed)
View
2021-02-16
4:39 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
RA CAPITAL MANAGEMENT L.P.5,290,481
5.3%
5,290,481increase
(New Position)
View
2021-02-16
4:11 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
Venrock Healthcare Capital Partners III L.P.4,040,000
4%
1,250,000increase
(+44.80%)
View
2021-02-12
4:30 pm
Unchanged
13GTrillium Therapeutics Inc.
TRIL
Vivo Capital IX LLC0
0%
0
(Unchanged)
View
2021-02-12
08:09 am
Purchase
13GTrillium Therapeutics Inc.
TRIL
Avoro Capital Advisors LLC5,800,000
5.7%
5,800,000increase
(New Position)
View
2020-05-11
4:13 pm
Sale
13GTrillium Therapeutics Inc.
TRIL
MORGAN STANLEY
MS
1,243,313
1.5%
-626,691decrease
(-33.51%)
View
2020-02-14
4:00 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
Sio Capital Management LLC2,751,186
9.81%
2,751,186increase
(New Position)
View
2020-02-14
10:31 am
Sale
13GTrillium Therapeutics Inc.
TRIL
Matrix Capital Management Company LP0
0%
-2,288,560decrease
(Position Closed)
View
2020-02-13
2:25 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
MORGAN STANLEY
MS
1,870,004
6.7%
220,526increase
(+13.37%)
View
2020-02-04
5:19 pm
Purchase
13DTrillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC6,586,363
8.7%
4,462,453increase
(+210.11%)
View
2020-02-03
4:31 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
Boxer Capital LLC4,425,000
5.9%
4,425,000increase
(New Position)
View
2020-02-03
4:03 pm
Purchase
13GTrillium Therapeutics Inc.
SCTPF
Vivo Capital IX LLC3,679,060
4.9%
3,679,060increase
(New Position)
View
2020-01-21
4:52 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
Venrock Healthcare Capital Partners III L.P.2,790,000
9.95%
2,790,000increase
(New Position)
View
2020-01-21
11:27 am
Unchanged
13GTrillium Therapeutics Inc.
TRIL
Empery Asset Management LP5,300,000
4.99%
0
(Unchanged)
View
2019-12-31
4:24 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
MORGAN STANLEY
MS
1,649,478
5.9%
1,126,323increase
(+215.29%)
View
2019-03-04
4:50 pm
Purchase
13GTrillium Therapeutics Inc.
TRIL
Empery Asset Management LP5,300,000
9.42%
5,300,000increase
(New Position)
View
Goto 0, 1, Next